Amgen Stock Analysis


USD 248.39  0.04  0.0161%   

The latest indifference towards the small price fluctuations of Amgen Inc could raise concerns from institutional investors as the firm is trading at a share price of 248.39 on very low momentum in volume. The company management teams did not add any value to Amgen investors in July. However, most investors can still diversify their portfolios with Amgen Inc to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 0.93. The very small Stock volatility is a good signal to institutional investors with longer-term investment horizons.
Please continue to Trending Equities.
The Amgen stock analysis report makes it easy to digest most publicly released information about Amgen and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Amgen Stock analysis module also helps to analyze the Amgen price relationship with some important fundamental indicators such as market cap and management efficiency.

Amgen Stock Analysis Notes

About 82.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.02. Amgen Inc recorded earning per share (EPS) of 9.7. The entity last dividend was issued on the 16th of May 2022. The firm had 2:1 split on the 22nd of November 1999. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 24200 people. For more info on Amgen Inc please contact Robert Bradway at 805 447-1010 or go to

Amgen Quarterly Cost of Revenue

1.51 Billion

Amgen Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Amgen's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Amgen Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Over 82.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Exercise or conversion by Robert Eckert of 20000 shares of Amgen subject to Rule 16b-3

Amgen Inc Upcoming and Recent Events

Earnings reports are used by Amgen to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Amgen previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report1st of February 2022
Next Financial Report26th of April 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End1st of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Amgen Largest EPS Surprises

Earnings surprises can significantly impact Amgen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Amgen SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Amgen prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Amgen investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Amgen Inc specific information freely available to individual and institutional investors to make a timely investment decision.
4th of August 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition. Entry into a Material Definitive Agreement
3rd of August 2022
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
18th of May 2022
Submission of Matters to a Vote of Security Holders
27th of April 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
24th of February 2022
Financial Statements and Exhibits. Entry into a Material Definitive Agreement
22nd of February 2022
Financial Statements and Exhibits. Entry into a Material Definitive Agreement
11th of February 2022
Unclassified Corporate Event
10th of February 2022
Unclassified Corporate Event

Amgen Thematic Classifications

In addition to having Amgen stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Macroaxis Index
Macroaxis power theme of selected equities with solid fundamentals
Robots And Drones
Cross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions
Drug manufacturing and delivery
Baby Boomer Prospects
Mega stocks, funds and ETFs that tend to appeal to people considering retirement from the work force
Giant Impact
Public companies with mega capitalization

Amgen Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Amgen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amgen Inc backward and forwards among themselves. Amgen's institutional investor refers to the entity that pools money to purchase Amgen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Blackrock IncCommon Shares46.8 M11.4 B
Vanguard Group IncCommon Shares46.1 M11.2 B
Primecap Management CoCommon Shares15.6 M3.8 B
Geode Capital Management LlcCommon Shares10.7 M2.6 B
Fmr LlcCommon Shares8.9 M2.2 B
Wells Fargo CompanyCommon Shares7.5 M1.8 B
Northern Trust CorpCommon Shares7.3 M1.8 B
Note, although Amgen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Amgen Market Capitalization

The company currently falls under 'Mega-Cap' category with current market capitalization of 138.7 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amgen's market, we take the total number of its shares issued and multiply it by Amgen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Amgen Profitablity

Amgen's profitability indicators refer to fundamental financial ratios that showcase Amgen's ability to generate income relative to its revenue or operating costs. If, let's say, Amgen is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Amgen's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Amgen's profitability requires more research than a typical breakdown of Amgen's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 21.75 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 48.99 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.49.
Last ReportedProjected for 2022
Return on Investment 18.54  16.48 
Return on Average Assets 0.1  0.10 
Return on Average Equity 0.72  0.60 
Return on Invested Capital 0.18  0.18 
Return on Sales 0.30  0.39 

Management Efficiency

The entity has return on total asset (ROA) of 9.91 % which means that it generated profit of $9.91 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 111.67 %, meaning that it created $111.67 on every $100 dollars invested by stockholders. Amgen management efficiency ratios could be used to measure how well amgen inc manages its routine affairs as well as how well it operates its assets and liabilities. Amgen Return on Average Assets are quite stable at the moment as compared to the past year. The company's current value of Return on Average Assets is estimated at 0.10. Return on Invested Capital is expected to rise to 0.18 this year, although the value of Return on Investment will most likely fall to 16.48. Amgen Tangible Assets Book Value per Share are quite stable at the moment as compared to the past year. The company's current value of Tangible Assets Book Value per Share is estimated at 61.17. Average Assets is expected to rise to about 69.9 B this year, although the value of Assets Non Current will most likely fall to about 41.3 B.
Last ReportedProjected for 2022
Book Value per Share 11.75  17.02 
Enterprise Value over EBIT 19.00  19.32 
Enterprise Value over EBITDA 13.48  12.52 
Price to Book Value 18.91  20.41 
Tangible Assets Book Value per Share 54.55  61.17 
Enterprise Value152.3 B158 B
Tangible Asset Value31.1 B33.1 B

Technical Drivers

As of the 13th of August 2022, Amgen shows the mean deviation of 0.7668, and Risk Adjusted Performance of 0.0819. Amgen Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Amgen Inc, which can be compared to its rivals. Please confirm Amgen Inc treynor ratio, and the relationship between the standard deviation and downside variance to decide if Amgen Inc is priced correctly, providing market reflects its regular price of 248.39 per share. Given that Amgen has jensen alpha of 0.0282, we suggest you to validate Amgen Inc's prevailing market performance to make sure the company can sustain itself at a future point.

Amgen Inc Price Movement Analysis

The output start index for this execution was zero with a total number of output elements of sixty-one. The Moving Average is predictive technique used to analyze Amgen Inc price data points by creating a series of averages of different subsets of Amgen entire price series.

Amgen Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Amgen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Amgen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Amgen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Amgen Outstanding Bonds

Amgen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Amgen Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Amgen bonds can be classified according to their maturity, which is the date when Amgen Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Amgen Technical and Predictive Indicators

Amgen Forecast Models

Amgen time-series forecasting models is one of many Amgen's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Amgen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Amgen Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Amgen stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Amgen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Amgen. By using and applying Amgen Stock analysis, traders can create a robust methodology for identifying Amgen entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin 29.40  30.72 
EBITDA Margin 0.43  0.51 
Gross Margin 0.75  0.73 
Profit Margin 0.23  0.28 
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 24200 people.

Current Amgen Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Amgen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Amgen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Amgen Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Amgen analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Amgen stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Amgen Inc, talking to its executives and customers, or listening to Amgen conference calls.
Amgen Analyst Advice Details

Amgen Stock Analysis Indicators

Amgen Inc stock analysis indicators help investors evaluate how Amgen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Amgen shares will generate the highest return on investment. By understating and applying Amgen stock analysis, traders can identify Amgen position entry and exit signals to maximize returns.
Quick Ratio0.90
Trailing Annual Dividend Rate6.88
Fifty Two Week Low198.64
Revenue Growth5.70%
Payout Ratio71.27%
Average Daily Volume Last 10 Day2.37M
Shares Short Prior Month18.51M
Average Daily Volume In Three Month3.1M
Earnings Growth-5.30%
Shares Percent Shares Out3.24%
Earnings Quarterly Growth-10.30%
Gross Margins75.21%
Forward Price Earnings13.03
Short Percent Of Float3.25%
Float Shares533.13M
Fifty Two Week High258.45
Fifty Day Average245.65
Enterprise Value To Ebitda12.60
Two Hundred Day Average232.11
Enterprise Value To Revenue6.18
Trailing Annual Dividend Yield2.79%
Please continue to Trending Equities. Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Amgen Stock analysis

When running Amgen Inc price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
132.9 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine Amgen value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.